|
UBXN2A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.575400E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.997480E-03 |
| Normal-vs-Stage2 |
1.849950E-02 |
| Normal-vs-Stage3 |
2.979700E-03 |
| Normal-vs-Stage4 |
4.11449999999647E-05 |
| Stage1-vs-Stage2 |
7.705600E-01 |
| Stage1-vs-Stage3 |
8.007600E-01 |
| Stage1-vs-Stage4 |
7.987800E-02 |
| Stage2-vs-Stage3 |
9.236600E-01 |
| Stage2-vs-Stage4 |
4.043000E-01 |
| Stage3-vs-Stage4 |
1.957040E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.579580E-03 |
| Normal-vs-AfricanAmerican |
1.683760E-01 |
| Normal-vs-Asian |
4.400200E-03 |
| Caucasian-vs-AfricanAmerican |
4.558400E-01 |
| Caucasian-vs-Asian |
6.887200E-01 |
| AfricanAmerican-vs-Asian |
3.633400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.223790E-03 |
| Normal-vs-Female |
1.196750E-03 |
| Male-vs-Female |
6.175000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.154030E-02 |
| Normal-vs-Age(41-60Yrs) |
3.442000E-04 |
| Normal-vs-Age(61-80Yrs) |
1.803910E-03 |
| Normal-vs-Age(81-100Yrs) |
1.783220E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.154400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.726400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.944600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.004000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.864400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.353600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.382600E-01 |
| Classical-VS-Follicular |
1.011150E-04 |
| Classical-VS-Other |
1.939370E-01 |
| Classical-VS-Normal |
2.377600E-02 |
| Tall-VS-Follicular |
2.174800E-01 |
| Tall-VS-Other |
5.085600E-01 |
| Tall-VS-Normal |
7.523900E-03 |
| Follicular-VS-Other |
9.982800E-01 |
| Follicular-VS-Normal |
2.67019999999896E-06 |
| Other-VS-Normal |
2.930500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.391180E-04 |
| Normal-vs-N1 |
3.969700E-04 |
| N0-vs-N1 |
3.884400E-01 |
|
|
